若见辉瞳

若见辉瞳

Biotech/Healthcare

Founded in 2025, Ruojian Huitong is an innovative drug developer focused on ophthalmology. Its two lead development pipelines are both first-in-class drug candidates with global patents.

Latest round: Angel (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-03-01